Pharmaceutical

Gilead adds investigational HIV vaccine to its portfoli...

Gilead and Aelix first teamed up in 2018 for a clinical research collaboration a...

Roche to acquire Poseida Therapeutics for $1.5bn

Roche has signed an agreement for the acquisition of Poseida Therapeutics in a d...

Shorla Oncology’s IMKELDI approved by FDA for leukaemia...

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI fo...

Pharmaceutical Technology Excellence Awards 2024: PCI P...

PCI Pharma Services is a winner in the Innovation and Business Expansion categor...

Adcendo raises $135m as ADC funding frenzy continues 

This latest raise is intended to accelerate the development of the biotech’s fou...

Sustainability in biopharma: Collaboration and technolo...

The biopharmaceutical industry is being called to take its sustainability effort...

Arrowhead and Sarepta link for rare genetic disease tre...

Arrowhead has entered a worldwide licensing and partnership agreement with Sarep...

FDA approves BridgeBio’s Attruby for ATTR-CM treatment

The US FDA has approved BridgeBio Pharma’s Attruby (acoramidis) for treating adu...

Amneal files again for FDA approval of first dihydroerg...

Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe a...

Zai Lab and Pfizer to commercialise XACDURO in China

Zai Lab and Pfizer have entered a strategic collaboration for the commercialisat...

Magazine: Pharma’s green shift with dry powder inhalers

Several pharmaceutical companies are advancing dry powder inhalers (DPIs) for re...

Novartis acquires Kate Therapeutics to advance gene the...

Novartis has announced the acquisition of Kate Therapeutics to enhance its portf...

UK point-of-care production of cell therapies could arr...

The UK’s proposed regulations would provide the legal framework for POC manufact...

J&J eyes FDA approval for injection-based Tremfya in ul...

Johnson & Johnson Innovation Medicine has submitted a request to the FDA to appr...

“No magic wand” for Novo Nordisk, as CagriSema pen supp...

Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supp...

Health Canada issues NOC to J&J’s CARVYKTI for multiple...

Health Canada has issued a Notice of Compliance (NOC) for Johnson & Johnson’s (J...